BNP Paribas Asset Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
BNP Paribas Asset Management's ATRC Position: Q1 2026 in Review
BNP Paribas Asset Management increased its AtriCure (ATRC) stake by 11% in Q1 2026, buying an estimated $3.46M and bringing the position to 1,060,806 shares worth $30.3M. The position accounts for 0.04% of the portfolio, ranked #456.
BNP Paribas Asset Management first reported a position in ATRC in Q4 2018 and has held it in 30 quarters since. The position peaked at $38M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- BNP Paribas Asset Management held 1,060,806 shares of AtriCure worth $30.3M as of Q1 2026.
- BNP Paribas Asset Management bought 101,512 AtriCure shares in Q1 2026, an estimated $3.46M.
- AtriCure made up 0.04% of BNP Paribas Asset Management's portfolio in Q1 2026, its #456 holding.
- BNP Paribas Asset Management first reported a position in AtriCure in Q4 2018 and has held it in 30 quarters since.
- BNP Paribas Asset Management's AtriCure position peaked at $38M in Q4 2025.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.